Coriell In The News
Business publication identifies Coriell Institute and its for-profit spinoff venture as crucial components for regional prosperity.
Already the world's leading source for human induced pluripotent stem cell lines, Coriell has reached a significant benchmark with its program.
Dr. Jeffrey Brenner, a MacArthur Fellow and prominent voice in the ongoing healthcare reform discussion, visited Coriell in January and shared his progressive vision with staff.
The New Jersey Technology Council identifies Coriell Life Sciences as the state's breakout tech organization.
Find a warm location and settle into a comfy chair with the fall 2014 edition of Discover Coriell. Read on for an exciting update regarding Coriell's alliance with the U.S. Air Force, learn more about the multi-variant risk reporting model powering Coriell's research study, and catch up on the Institute's revamped online biorepository catalog.
An in-depth CBS News article features samples from the Coriell Biobank researchers are using to examine a potential association between resistance to Ebola virus and a rare genetic disease.
A health writer with the Wall Street Journal cited Coriell Institute's preeminent biobank.
Cutting-edge research conducted by Coriell and The Ohio State University is the focus of a medical news publication and a top genetics conference.
A group of Coriell scientists traveled to San Diego in October and represented the Institute at the American Society of Human Genetics annual meeting.
John P. Sheridan Jr., CEO of the Cooper University Health System and a longtime partner to the Coriell Institute, died September 28th in a fire at his Central New Jersey home.
Giving to Coriell
As a non-profit institute, Coriell is fortunate to be engaged in several federally-funded awards. However, we rely on private philanthropy for our more cutting-edge, independent research. Thank you for supporting science!